Lv4
570 积分 2024-03-15 加入
Discovery of novel aminopyrimidine-hydroxamate derivatives as dual FLT3/HDAC inhibitors: Design, synthesis, and anti-hematologic malignancy evaluation
12小时前
已完结
Quizartinib for Newly Diagnosed FLT3 -Internal Tandem Duplication–Negative AML
6天前
已关闭
Nintedanib is a potent FLT3 inhibitor with activity against FLT3-ITD and overcomes the gatekeeper F691L resistance mutation in acute myeloid leukemia
8天前
已完结
FLT3 mutational analysis in acute myeloid leukemia: Advantages and pitfalls with different approaches
8天前
已完结
A review of FLT3 inhibitors in acute myeloid leukemia
8天前
已完结
Recent advance in macrocyclic CDK inhibitors
8天前
已完结
Single-Cell Lineage Tracing Uncovers Resistance Signatures and Sensitizing Strategies to FLT3 Inhibitors in Acute Myeloid Leukemia
8天前
已完结
Emerging Strategies to Inhibit the G1/S Transition for Cancer Therapy
8天前
已完结
Design and synthesis of novel cyclin-dependent kinase 4/6(CDK4/6) and histone deacetylase (HDAC) dual inhibitors: In vitro and in vivo anticancer activity
8天前
已完结
HDAC Inhibition Unlocks Tumor Plasticity and Enhances Immunotherapy Response in Myc-Driven Small Cell Lung Cancer
8天前
已完结
皖公网安备34019202002308
